ProfileGDS4459 / ENSG00000162065
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 36% 24% 40% 25% 44% 49% 48% 40% 36% 49% 34% 44% 41% 36% 43% 43% 48% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.9836
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.5724
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.9540
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.725
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.1744
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.3549
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.3648
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.9640
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.836
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.3849
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.7634
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.1344
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.141
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9836
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.0843
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.1843
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.3148